MCKESSON CORP

Wholesale-Drugs, Proprietaries & Druggists' Sundries·IRVING, TX·FY end 03/31·CIK 927653

CEO Pay Ratio

295:1

Brian S. Tyler

CEO Total Comp

$20.2M

Brian S. Tyler

Median Employee

$68,406

Revenue

$403.4B

FY 2026

Net Income

$4.8B

FY 2026

Free Cash Flow

$5.7B

FY 2026

Net Margin

1.2%

Insider Net (180d)

-$4.0M

0 buys / 6 sales

CEO Pay Accountability

CEO comp as % of net income

0.61%

For every $1,000 of profit, $6.12 flows to the CEO.

CEO comp as % of buybacks

0.64%

CEO comp equals 6.4‰ of cash returned to shareholders via buybacks.

5-year history · USD

Metric	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	Trend
Revenue	$403.4B	$359.1B	$309.0B	$276.7B	$264.0B
Gross Profit	$14.6B	$13.3B	$12.8B	$12.4B	$13.1B
Operating Income	$6.2B	$4.4B	$3.9B	$4.4B	$2.0B
Net Income	$4.8B	$3.3B	$3.0B	$3.6B	$1.1B
Operating CF	$6.2B	$6.1B	$4.3B	$5.2B	$4.4B
Capex	$436.0M	$537.0M	$431.0M	$390.0M	$388.0M
Free Cash Flow	$5.7B	$5.5B	$3.9B	$4.8B	$4.0B
Buybacks	$4.8B	$3.1B	$3.0B	$3.6B	$3.5B
Dividends	$381.0M	$345.0M	$314.0M	$292.0M	$277.0M

Gross Margin	3.6%	3.7%	4.2%	4.5%	5.0%
Operating Margin	1.5%	1.2%	1.3%	1.6%	0.8%
Net Margin	1.2%	0.9%	1.0%	1.3%	0.4%
FCF Margin	1.4%	1.5%	1.3%	1.7%	1.5%
R&D / Revenue	—	—	—	—	—	—
Effective Tax	17.8%	20.1%	16.6%	19.5%	33.0%
Debt / Equity	-3.00	-2.73	-2.86	-3.01	-2.59
Buybacks / FCF	83.1%	56.7%	77.9%	76.3%	86.9%

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Brian S. TylerChief Executive Officer	$1.5M	$14.5M	—	$3.7M	$450.4K	$20.2M
Britt J. VitaloneExecutive Vice President and Chief Financial Officer	$1.0M	$5.0M	—	$1.5M	$131.6K	$7.7M
Michele LauExecutive Vice President and Chief Legal Officer	$720.4K	$3.0M	—	$857.3K	$647.9K	$5.2M
LeAnn B. SmithExecutive Vice President and Chief Human Resources Officer	$658.8K	$2.2M	—	$783.9K	$74.3K	$3.7M
Thomas L. RodgersExecutive Vice President and Chief Strategy and Business Development Officer	$631.1K	$1.8M	—	$751.0K	$79.9K	$3.2M